SS 21 - Radiation and Cancer Biology 3: Normal Tissue Injury &  Biomarkers

Presentations

• 10:45am - 10:55am PT

  Blood Biomarkers of Survival in Patients Receiving Stereotactic Radiotherapy with or without Immunotherapy for Oligometastatic Disease

  Speaker: Juan Zafra-Martin, MD, PhD - Hospital Universitario Virgen de la Victoria, Málaga
• 10:45am - 12:00pm PT

  Radiation and Cancer Biology 3: Normal Tissue Injury &  Biomarkers

  Speaker: Omar Mian, MD, PhD - Fred Hutchinson Research Center, Seattle
• 10:45am - 12:00pm PT

  Radiation and Cancer Biology 3: Normal Tissue Injury &  Biomarkers

  Speaker: Oscar Padilla, MD - Mount Sinai Hospital, New York
• 10:55am - 11:05am PT

  Attenuation of Lung Fibrosis by Multifield Fractionated Rasterscanning FLASH Carbon Ion Radiotherapy

  Speaker: Mahmoud Moustafa, DVM, PhD - University Hospital Heidelberg, Heidelberg
• 11:05am - 11:15am PT

  The Critical Role of Instantaneous Dose Rate in Mitigating Lethality and Radiation-Induced Toxicities in Murine Total-Body Irradiation: A Comparative Analysis of Dose Rate Regimens

  Speaker: Hongyu Zhu, PhD - Sun Yat-Sen University Cancer Center, Guang Dong Province
• 11:15am - 11:25am PT

  Neutrophil Extracellular Traps Formation Mediated By Senescent Fibroblast Drives Radiation-Induced Lung Fibrosis

  Speaker: Ying Dong, - Shandong Cancer Hospital and Institute, Jinan
• 11:25am - 11:35am PT

  Osteoclast-Neuron Crosstalk Drives Radiation-Induced Pain

  Speaker: Sun Park, PhD - Wake Forest School of Medicine, Winston-Salem
• 11:35am - 11:45am PT

  Impact of Radiotherapy Site, Modality, and Dose on Subsequent Clonal Hematopoiesis

  Speaker: Alexander Goglia, MD, PhD - Memorial Sloan Kettering Cancer Center, New York
• 11:45am - 11:55am PT

  Discussant

  Speaker: Brian Marples, PhD, FASTRO - University of Rochester, Rochester